Skip to main content
    X

    Xtant Medical Holdings Inc (XTNT)

    Official site

    HEALTHCARE • MEDICAL DEVICES • AMEX

    $0.27
    -0.00 (-1.31%)

    Market Cap: $38.12M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Xtant Medical Holdings Inc (XTNT) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Xtant Medical Holdings (XTNT) to earn -$0.08 per share in the fiscal year ending Dec 31, 2026, on revenue of $99.44M. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.03.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 10.9%.

    Fiscal year ending Dec 31, 2026
    -$0.08
    EPS consensus, revenue $99.44M
    Fiscal year ending Dec 31, 2027
    -$0.03
    EPS consensus, revenue $110.23M
    Next report
    Mar 29, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.08-$0.08 to -$0.081$99.44M$97.80M to $100.53M3
    Dec 31, 2027-$0.03-$0.06 to -$0.013$110.23M$109.60M to $110.60M3

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.00-$0.01 to $0.005$28.83M$24.78M to $31.50M5

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 0 upward and 2 downward EPS revisions. Cuts outnumber raises in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202601
    Fiscal year ending Dec 31, 202701

    EPS Trend

    The EPS consensus for the fiscal year ending Dec 31, 2026 has held over the last 90 days.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$0.08N/A-$0.08-$0.08-$0.08N/A
    Fiscal year ending Dec 31, 2027-$0.03-$0.04-$0.01-$0.01-$0.01N/A

    Frequently Asked Questions About XTNT

    What is the XTNT stock forecast?

    Consensus analyst estimates put Xtant Medical Holdings's EPS at -$0.08 for the fiscal year ending Dec 31, 2026, on revenue of $99.44M.

    What EPS do analysts expect from XTNT next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.08, with estimates from -$0.08 to -$0.08 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.03, with estimates from -$0.06 to -$0.01 from 3 analysts.

    What revenue do analysts expect from Xtant Medical Holdings next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $99.44M, with estimates from $97.80M to $100.53M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $110.23M, with estimates from $109.60M to $110.60M.

    How many analysts cover XTNT?

    1 analyst estimates EPS for Xtant Medical Holdings for the fiscal year ending Dec 31, 2026.